ClinicalTrials.gg

Drug

Liposomal Bupivacaine clinical trials

A product of Bupivacaine; its studies count on that page too.

studies test it
296
open now
49
in phase 3
49
first study started
2011

Keep track of what changes. Save the Liposomal Bupivacaine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

294 studies that test it; most in 2019 (39); 1 more planned to start later

Studies that test Liposomal Bupivacaine, by start year
YearStudies
20112
201210
201313
201429
201524
201620
201718
201827
201939
202017
202123
202213
202311
202421
20258
202619

By phase

A phase 1/2 study counts in both.

Early Phase 1
7
Phase 1
18
Phase 2
31
Phase 3
49
Phase 4
165
No phase
36

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 37 · Other 259

Pacira Pharmaceuticals, Inc (34) · Mayo Clinic (11) · University of Minnesota (9) · Wake Forest University Health Sciences (9) · Beijing Tiantan Hospital (6) · St. Luke's Hospital, Pennsylvania (4) · The Cleveland Clinic (4) · Indiana University (4)

Often tested with

Tested in the same studies.

Ropivacaine (10) · Dexamethasone (6) · Epinephrine (5) · Hydromorphone (2) · Methylprednisolone (2) · Fentanyl (1) · Therapeutic Procedure (1) · Complementary or Alternative Medical Procedure (1)

Studies

Open first, then newest update. How each study uses Liposomal Bupivacaine is read from its arms, and is right about nine times in ten.

Testing it · 296

See all 296 studies that test Liposomal Bupivacaine →

Given in every arm · 12 — Liposomal Bupivacaine is usual care beside what is tested
As the comparator · 10 — what is tested is compared with Liposomal Bupivacaine